U.S. Physical Therapy, Inc. (NYSE: USPH) Stock Competitors & Peer Comparison
See USPH's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for USPH and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| USPH | $87.02 | +3.71% | 1.3B | 34.24 | $2.54 | +2.13% |
| HCA | $465.75 | +2.39% | 100.8B | 16.08 | $28.96 | +0.66% |
| THC | $272.32 | +2.23% | 21.9B | 15.79 | $17.24 | N/A |
| EHC | $121.67 | -0.03% | 12B | 20.83 | $5.84 | +0.64% |
| FMS | $21.41 | -2.42% | 11.5B | 8.05 | $2.66 | +4.05% |
| DVA | $175.35 | -6.23% | 11.2B | 13.68 | $12.80 | N/A |
| UHS | $185.61 | +1.82% | 10.9B | 8.24 | $22.54 | +0.43% |
| ENSG | $176.00 | +1.70% | 10.3B | 25.51 | $6.90 | +0.15% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
| PACS | $47.72 | +4.08% | 7.6B | 25.25 | $1.89 | N/A |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
USPH vs HCA Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, HCA has a market cap of 100.8B. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while HCA trades at $465.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas HCA's P/E ratio is 16.08. In terms of profitability, USPH's ROE is -0.01%, compared to HCA's ROE of -1.13%. Regarding short-term risk, USPH is more volatile compared to HCA. This indicates higher risk in terms of short-term price fluctuations for USPH.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
USPH vs THC Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, THC has a market cap of 21.9B. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while THC trades at $272.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas THC's P/E ratio is 15.79. In terms of profitability, USPH's ROE is -0.01%, compared to THC's ROE of +0.51%. Regarding short-term risk, USPH is more volatile compared to THC. This indicates higher risk in terms of short-term price fluctuations for USPH.Check THC's competition here
Encompass Health Corporation (NYSE: EHC)
USPH vs EHC Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, EHC has a market cap of 12B. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while EHC trades at $121.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas EHC's P/E ratio is 20.83. In terms of profitability, USPH's ROE is -0.01%, compared to EHC's ROE of +0.25%. Regarding short-term risk, USPH is more volatile compared to EHC. This indicates higher risk in terms of short-term price fluctuations for USPH.Check EHC's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
USPH vs FMS Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, FMS has a market cap of 11.5B. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while FMS trades at $21.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas FMS's P/E ratio is 8.05. In terms of profitability, USPH's ROE is -0.01%, compared to FMS's ROE of +0.07%. Regarding short-term risk, USPH is less volatile compared to FMS. This indicates lower risk in terms of short-term price fluctuations for USPH.Check FMS's competition here
DaVita Inc. (NYSE: DVA)
USPH vs DVA Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, DVA has a market cap of 11.2B. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while DVA trades at $175.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas DVA's P/E ratio is 13.68. In terms of profitability, USPH's ROE is -0.01%, compared to DVA's ROE of -1.24%. Regarding short-term risk, USPH is less volatile compared to DVA. This indicates lower risk in terms of short-term price fluctuations for USPH.Check DVA's competition here
Universal Health Services, Inc. (NYSE: UHS)
USPH vs UHS Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, UHS has a market cap of 10.9B. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while UHS trades at $185.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas UHS's P/E ratio is 8.24. In terms of profitability, USPH's ROE is -0.01%, compared to UHS's ROE of +0.21%. Regarding short-term risk, USPH is more volatile compared to UHS. This indicates higher risk in terms of short-term price fluctuations for USPH.Check UHS's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
USPH vs ENSG Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, ENSG has a market cap of 10.3B. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while ENSG trades at $176.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas ENSG's P/E ratio is 25.51. In terms of profitability, USPH's ROE is -0.01%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, USPH is more volatile compared to ENSG. This indicates higher risk in terms of short-term price fluctuations for USPH.Check ENSG's competition here
Oak Street Health, Inc. (NYSE: OSH)
USPH vs OSH Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas OSH's P/E ratio is -17.65. In terms of profitability, USPH's ROE is -0.01%, compared to OSH's ROE of +4.64%. Regarding short-term risk, USPH is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for USPH.Check OSH's competition here
PACS Group, Inc. (NYSE: PACS)
USPH vs PACS Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, PACS has a market cap of 7.6B. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while PACS trades at $47.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas PACS's P/E ratio is 25.25. In terms of profitability, USPH's ROE is -0.01%, compared to PACS's ROE of +0.27%. Regarding short-term risk, USPH is less volatile compared to PACS. This indicates lower risk in terms of short-term price fluctuations for USPH.Check PACS's competition here
Chemed Corporation (NYSE: CHE)
USPH vs CHE Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, CHE has a market cap of 6.7B. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while CHE trades at $516.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas CHE's P/E ratio is 23.88. In terms of profitability, USPH's ROE is -0.01%, compared to CHE's ROE of +0.29%. Regarding short-term risk, USPH is more volatile compared to CHE. This indicates higher risk in terms of short-term price fluctuations for USPH.Check CHE's competition here
Hims & Hers Health, Inc. (NYSE: HIMS)
USPH vs HIMS Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, HIMS has a market cap of 6.6B. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while HIMS trades at $29.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas HIMS's P/E ratio is -45.66. In terms of profitability, USPH's ROE is -0.01%, compared to HIMS's ROE of -0.30%. Regarding short-term risk, USPH is less volatile compared to HIMS. This indicates lower risk in terms of short-term price fluctuations for USPH.Check HIMS's competition here
LHC Group, Inc. (NASDAQ: LHCG)
USPH vs LHCG Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas LHCG's P/E ratio is 82.83. In terms of profitability, USPH's ROE is -0.01%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, USPH is more volatile compared to LHCG. This indicates higher risk in terms of short-term price fluctuations for USPH.Check LHCG's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
USPH vs CON Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, CON has a market cap of 4.9B. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while CON trades at $38.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas CON's P/E ratio is 24.37. In terms of profitability, USPH's ROE is -0.01%, compared to CON's ROE of +0.47%. Regarding short-term risk, USPH is more volatile compared to CON. This indicates higher risk in terms of short-term price fluctuations for USPH.Check CON's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
USPH vs OPCH Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, OPCH has a market cap of 4.7B. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while OPCH trades at $31.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas OPCH's P/E ratio is 18.23. In terms of profitability, USPH's ROE is -0.01%, compared to OPCH's ROE of +0.16%. Regarding short-term risk, USPH is more volatile compared to OPCH. This indicates higher risk in terms of short-term price fluctuations for USPH.Check OPCH's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
USPH vs LFST Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, LFST has a market cap of 4.7B. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while LFST trades at $12.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas LFST's P/E ratio is 92.04. In terms of profitability, USPH's ROE is -0.01%, compared to LFST's ROE of +0.03%. Regarding short-term risk, USPH is less volatile compared to LFST. This indicates lower risk in terms of short-term price fluctuations for USPH.Check LFST's competition here
National HealthCare Corporation (AMEX: NHC)
USPH vs NHC Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, NHC has a market cap of 3.9B. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while NHC trades at $247.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas NHC's P/E ratio is 31.49. In terms of profitability, USPH's ROE is -0.01%, compared to NHC's ROE of +0.13%. Regarding short-term risk, USPH is more volatile compared to NHC. This indicates higher risk in terms of short-term price fluctuations for USPH.Check NHC's competition here
Amedisys, Inc. (NASDAQ: AMED)
USPH vs AMED Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas AMED's P/E ratio is 39.30. In terms of profitability, USPH's ROE is -0.01%, compared to AMED's ROE of +0.04%. Regarding short-term risk, USPH is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for USPH.Check AMED's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
USPH vs ACHC Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, ACHC has a market cap of 2.9B. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while ACHC trades at $31.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas ACHC's P/E ratio is 15.79. In terms of profitability, USPH's ROE is -0.01%, compared to ACHC's ROE of -0.50%. Regarding short-term risk, USPH is less volatile compared to ACHC. This indicates lower risk in terms of short-term price fluctuations for USPH.Check ACHC's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
USPH vs AVAH Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, AVAH has a market cap of 2.8B. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while AVAH trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas AVAH's P/E ratio is 18.75. In terms of profitability, USPH's ROE is -0.01%, compared to AVAH's ROE of +1.50%. Regarding short-term risk, USPH is more volatile compared to AVAH. This indicates higher risk in terms of short-term price fluctuations for USPH.Check AVAH's competition here
Guardian Pharmacy Services, Inc. (NYSE: GRDN)
USPH vs GRDN Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, GRDN has a market cap of 2.7B. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while GRDN trades at $41.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas GRDN's P/E ratio is 36.72. In terms of profitability, USPH's ROE is -0.01%, compared to GRDN's ROE of +0.31%. Regarding short-term risk, USPH is less volatile compared to GRDN. This indicates lower risk in terms of short-term price fluctuations for USPH.Check GRDN's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
USPH vs BKD Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, BKD has a market cap of 2.4B. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while BKD trades at $10.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas BKD's P/E ratio is -17.37. In terms of profitability, USPH's ROE is -0.01%, compared to BKD's ROE of +4.06%. Regarding short-term risk, USPH is more volatile compared to BKD. This indicates higher risk in terms of short-term price fluctuations for USPH.Check BKD's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
USPH vs MD Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, MD has a market cap of 2.3B. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while MD trades at $28.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas MD's P/E ratio is 12.52. In terms of profitability, USPH's ROE is -0.01%, compared to MD's ROE of +0.20%. Regarding short-term risk, USPH is less volatile compared to MD. This indicates lower risk in terms of short-term price fluctuations for USPH.Check MD's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
USPH vs ADUS Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, ADUS has a market cap of 2.2B. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while ADUS trades at $118.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas ADUS's P/E ratio is 17.67. In terms of profitability, USPH's ROE is -0.01%, compared to ADUS's ROE of +0.10%. Regarding short-term risk, USPH is more volatile compared to ADUS. This indicates higher risk in terms of short-term price fluctuations for USPH.Check ADUS's competition here
Select Medical Holdings Corporation (NYSE: SEM)
USPH vs SEM Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, SEM has a market cap of 2B. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas SEM's P/E ratio is 15.43. In terms of profitability, USPH's ROE is -0.01%, compared to SEM's ROE of +0.08%. Regarding short-term risk, USPH is more volatile compared to SEM. This indicates higher risk in terms of short-term price fluctuations for USPH.Check SEM's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
USPH vs SGRY Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, SGRY has a market cap of 2B. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while SGRY trades at $15.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas SGRY's P/E ratio is 39.72. In terms of profitability, USPH's ROE is -0.01%, compared to SGRY's ROE of -0.05%. Regarding short-term risk, USPH is less volatile compared to SGRY. This indicates lower risk in terms of short-term price fluctuations for USPH.Check SGRY's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
USPH vs ASTH Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, ASTH has a market cap of 1.9B. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while ASTH trades at $38.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas ASTH's P/E ratio is 46.48. In terms of profitability, USPH's ROE is -0.01%, compared to ASTH's ROE of +0.05%. Regarding short-term risk, USPH is less volatile compared to ASTH. This indicates lower risk in terms of short-term price fluctuations for USPH.Check ASTH's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
USPH vs AMEH Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas AMEH's P/E ratio is 39.25. In terms of profitability, USPH's ROE is -0.01%, compared to AMEH's ROE of +0.05%. Regarding short-term risk, USPH is less volatile compared to AMEH. This indicates lower risk in terms of short-term price fluctuations for USPH.Check AMEH's competition here
Ardent Health Inc. (NYSE: ARDT)
USPH vs ARDT Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, ARDT has a market cap of 1.7B. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while ARDT trades at $12.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas ARDT's P/E ratio is 9.77. In terms of profitability, USPH's ROE is -0.01%, compared to ARDT's ROE of +0.05%. Regarding short-term risk, USPH is more volatile compared to ARDT. This indicates higher risk in terms of short-term price fluctuations for USPH.Check ARDT's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
USPH vs SNDA Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, SNDA has a market cap of 1.7B. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while SNDA trades at $34.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas SNDA's P/E ratio is -5.55. In terms of profitability, USPH's ROE is -0.01%, compared to SNDA's ROE of -0.26%. Regarding short-term risk, USPH is more volatile compared to SNDA. This indicates higher risk in terms of short-term price fluctuations for USPH.Check SNDA's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
USPH vs AMN Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, AMN has a market cap of 1.6B. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while AMN trades at $41.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas AMN's P/E ratio is 13.81. In terms of profitability, USPH's ROE is -0.01%, compared to AMN's ROE of +0.15%. Regarding short-term risk, USPH is less volatile compared to AMN. This indicates lower risk in terms of short-term price fluctuations for USPH.Check AMN's competition here
Agilon Health, Inc. (NYSE: AGL)
USPH vs AGL Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, AGL has a market cap of 1.5B. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while AGL trades at $91.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas AGL's P/E ratio is -5.95. In terms of profitability, USPH's ROE is -0.01%, compared to AGL's ROE of -1.19%. Regarding short-term risk, USPH is less volatile compared to AGL. This indicates lower risk in terms of short-term price fluctuations for USPH.Check AGL's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
USPH vs HCSG Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, HCSG has a market cap of 1.5B. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while HCSG trades at $21.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas HCSG's P/E ratio is 17.20. In terms of profitability, USPH's ROE is -0.01%, compared to HCSG's ROE of +0.24%. Regarding short-term risk, USPH is more volatile compared to HCSG. This indicates higher risk in terms of short-term price fluctuations for USPH.Check HCSG's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
USPH vs PNTG Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, PNTG has a market cap of 1.4B. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while PNTG trades at $41.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas PNTG's P/E ratio is 31.42. In terms of profitability, USPH's ROE is -0.01%, compared to PNTG's ROE of +0.10%. Regarding short-term risk, USPH is more volatile compared to PNTG. This indicates higher risk in terms of short-term price fluctuations for USPH.Check PNTG's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
USPH vs NUTX Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, NUTX has a market cap of 1.4B. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while NUTX trades at $198.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas NUTX's P/E ratio is 7.87. In terms of profitability, USPH's ROE is -0.01%, compared to NUTX's ROE of +0.52%. Regarding short-term risk, USPH is less volatile compared to NUTX. This indicates lower risk in terms of short-term price fluctuations for USPH.Check NUTX's competition here
Innovage Holding Corp. (NASDAQ: INNV)
USPH vs INNV Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, INNV has a market cap of 1.2B. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while INNV trades at $9.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas INNV's P/E ratio is -457.50. In terms of profitability, USPH's ROE is -0.01%, compared to INNV's ROE of -0.01%. Regarding short-term risk, USPH is less volatile compared to INNV. This indicates lower risk in terms of short-term price fluctuations for USPH.Check INNV's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
USPH vs BKDT Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas BKDT's P/E ratio is N/A. In terms of profitability, USPH's ROE is -0.01%, compared to BKDT's ROE of +4.06%. Regarding short-term risk, USPH is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for USPH.Check BKDT's competition here
Talkspace, Inc. (NASDAQ: TALK)
USPH vs TALK Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, TALK has a market cap of 870.6M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while TALK trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas TALK's P/E ratio is 774.34. In terms of profitability, USPH's ROE is -0.01%, compared to TALK's ROE of +0.00%. Regarding short-term risk, USPH is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for USPH.Check TALK's competition here
Enhabit, Inc. (NYSE: EHAB)
USPH vs EHAB Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas EHAB's P/E ratio is -197.14. In terms of profitability, USPH's ROE is -0.01%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, USPH is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for USPH.Check EHAB's competition here
Starling Oncology, Inc. (NASDAQ: STLN)
USPH vs STLN Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, STLN has a market cap of 662.9M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while STLN trades at $6.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas STLN's P/E ratio is -21.72. In terms of profitability, USPH's ROE is -0.01%, compared to STLN's ROE of +2.10%. Regarding short-term risk, USPH is less volatile compared to STLN. This indicates lower risk in terms of short-term price fluctuations for USPH.Check STLN's competition here
GMR Solutions Inc. (NYSE: GMRS)
USPH vs GMRS Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, GMRS has a market cap of 566.1M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while GMRS trades at $10.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas GMRS's P/E ratio is -5.16. In terms of profitability, USPH's ROE is -0.01%, compared to GMRS's ROE of +0.16%. Regarding short-term risk, USPH is less volatile compared to GMRS. This indicates lower risk in terms of short-term price fluctuations for USPH.Check GMRS's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
USPH vs TOI Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, TOI has a market cap of 512.9M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while TOI trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas TOI's P/E ratio is -14.25. In terms of profitability, USPH's ROE is -0.01%, compared to TOI's ROE of +2.10%. Regarding short-term risk, USPH is less volatile compared to TOI. This indicates lower risk in terms of short-term price fluctuations for USPH.Check TOI's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
USPH vs MCTA Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas MCTA's P/E ratio is 419.36. In terms of profitability, USPH's ROE is -0.01%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, USPH is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for USPH.Check MCTA's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
USPH vs SRTA Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, SRTA has a market cap of 414.9M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while SRTA trades at $4.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas SRTA's P/E ratio is -22.11. In terms of profitability, USPH's ROE is -0.01%, compared to SRTA's ROE of +0.14%. Regarding short-term risk, USPH is more volatile compared to SRTA. This indicates higher risk in terms of short-term price fluctuations for USPH.Check SRTA's competition here
Auna S.A. (NYSE: AUNA)
USPH vs AUNA Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, AUNA has a market cap of 401.9M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while AUNA trades at $5.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas AUNA's P/E ratio is 4.89. In terms of profitability, USPH's ROE is -0.01%, compared to AUNA's ROE of +0.01%. Regarding short-term risk, USPH is more volatile compared to AUNA. This indicates higher risk in terms of short-term price fluctuations for USPH.Check AUNA's competition here
Community Health Systems, Inc. (NYSE: CYH)
USPH vs CYH Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, CYH has a market cap of 401.9M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while CYH trades at $2.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas CYH's P/E ratio is 3.90. In terms of profitability, USPH's ROE is -0.01%, compared to CYH's ROE of +0.21%. Regarding short-term risk, USPH is less volatile compared to CYH. This indicates lower risk in terms of short-term price fluctuations for USPH.Check CYH's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
USPH vs VMD Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, VMD has a market cap of 373.3M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while VMD trades at $9.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas VMD's P/E ratio is 27.22. In terms of profitability, USPH's ROE is -0.01%, compared to VMD's ROE of +0.10%. Regarding short-term risk, USPH is more volatile compared to VMD. This indicates higher risk in terms of short-term price fluctuations for USPH.Check VMD's competition here
Capital Senior Living Corporation (NYSE: CSU)
USPH vs CSU Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas CSU's P/E ratio is 0.67. In terms of profitability, USPH's ROE is -0.01%, compared to CSU's ROE of -0.33%. Regarding short-term risk, USPH is less volatile compared to CSU. This indicates lower risk in terms of short-term price fluctuations for USPH.Check CSU's competition here
The Joint Corp. (NASDAQ: JYNT)
USPH vs JYNT Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, JYNT has a market cap of 101.7M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while JYNT trades at $7.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas JYNT's P/E ratio is 47.93. In terms of profitability, USPH's ROE is -0.01%, compared to JYNT's ROE of +0.22%. Regarding short-term risk, USPH is more volatile compared to JYNT. This indicates higher risk in terms of short-term price fluctuations for USPH.Check JYNT's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
USPH vs FVE Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas FVE's P/E ratio is -5.64. In terms of profitability, USPH's ROE is -0.01%, compared to FVE's ROE of -0.15%. Regarding short-term risk, USPH is more volatile compared to FVE. This indicates higher risk in terms of short-term price fluctuations for USPH.Check FVE's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
USPH vs KDLYW Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas KDLYW's P/E ratio is N/A. In terms of profitability, USPH's ROE is -0.01%, compared to KDLYW's ROE of -1.05%. Regarding short-term risk, USPH is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for USPH.Check KDLYW's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
USPH vs AIRS Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, AIRS has a market cap of 93.7M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while AIRS trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas AIRS's P/E ratio is -43.33. In terms of profitability, USPH's ROE is -0.01%, compared to AIRS's ROE of -0.13%. Regarding short-term risk, USPH is less volatile compared to AIRS. This indicates lower risk in terms of short-term price fluctuations for USPH.Check AIRS's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
USPH vs PARK Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, PARK has a market cap of 93.2M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while PARK trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas PARK's P/E ratio is 26.49. In terms of profitability, USPH's ROE is -0.01%, compared to PARK's ROE of -0.18%. Regarding short-term risk, USPH is less volatile compared to PARK. This indicates lower risk in terms of short-term price fluctuations for USPH.Check PARK's competition here
biote Corp. (NASDAQ: BTMD)
USPH vs BTMD Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, BTMD has a market cap of 46.5M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while BTMD trades at $1.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas BTMD's P/E ratio is 9.59. In terms of profitability, USPH's ROE is -0.01%, compared to BTMD's ROE of -0.09%. Regarding short-term risk, USPH is less volatile compared to BTMD. This indicates lower risk in terms of short-term price fluctuations for USPH.Check BTMD's competition here
AlerisLife Inc. (NASDAQ: ALR)
USPH vs ALR Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas ALR's P/E ratio is -1.11. In terms of profitability, USPH's ROE is -0.01%, compared to ALR's ROE of -0.15%. Regarding short-term risk, USPH is more volatile compared to ALR. This indicates higher risk in terms of short-term price fluctuations for USPH.Check ALR's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
USPH vs EUDA Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, EUDA has a market cap of 44M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while EUDA trades at $14.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas EUDA's P/E ratio is -12.61. In terms of profitability, USPH's ROE is -0.01%, compared to EUDA's ROE of -5.06%. Regarding short-term risk, USPH is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for USPH.Check EUDA's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
USPH vs CCEL Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, CCEL has a market cap of 37.5M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while CCEL trades at $4.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas CCEL's P/E ratio is -20.22. In terms of profitability, USPH's ROE is -0.01%, compared to CCEL's ROE of +0.16%. Regarding short-term risk, USPH is less volatile compared to CCEL. This indicates lower risk in terms of short-term price fluctuations for USPH.Check CCEL's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
USPH vs IMAC Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas IMAC's P/E ratio is -2.27. In terms of profitability, USPH's ROE is -0.01%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, USPH is more volatile compared to IMAC. This indicates higher risk in terms of short-term price fluctuations for USPH.Check IMAC's competition here
DocGo Inc. (NASDAQ: DCGO)
USPH vs DCGO Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, DCGO has a market cap of 25.6M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while DCGO trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas DCGO's P/E ratio is -0.14. In terms of profitability, USPH's ROE is -0.01%, compared to DCGO's ROE of -1.16%. Regarding short-term risk, USPH is less volatile compared to DCGO. This indicates lower risk in terms of short-term price fluctuations for USPH.Check DCGO's competition here
P3 Health Partners Inc. (NASDAQ: PIIIW)
USPH vs PIIIW Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, PIIIW has a market cap of 19.5M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while PIIIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas PIIIW's P/E ratio is N/A. In terms of profitability, USPH's ROE is -0.01%, compared to PIIIW's ROE of +1.61%. Regarding short-term risk, USPH is less volatile compared to PIIIW. This indicates lower risk in terms of short-term price fluctuations for USPH.Check PIIIW's competition here
Cano Health, Inc. (NYSE: CANO-WT)
USPH vs CANO-WT Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, USPH's ROE is -0.01%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, USPH is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for USPH.Check CANO-WT's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
USPH vs AIH Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas AIH's P/E ratio is -2.78. In terms of profitability, USPH's ROE is -0.01%, compared to AIH's ROE of +1.16%. Regarding short-term risk, USPH is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for USPH.Check AIH's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
USPH vs PIII Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, PIII has a market cap of 13M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while PIII trades at $3.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas PIII's P/E ratio is -0.12. In terms of profitability, USPH's ROE is -0.01%, compared to PIII's ROE of +1.61%. Regarding short-term risk, USPH is less volatile compared to PIII. This indicates lower risk in terms of short-term price fluctuations for USPH.Check PIII's competition here
Cano Health, Inc. (NYSE: CANO)
USPH vs CANO Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas CANO's P/E ratio is -0.01. In terms of profitability, USPH's ROE is -0.01%, compared to CANO's ROE of -1.49%. Regarding short-term risk, USPH is less volatile compared to CANO. This indicates lower risk in terms of short-term price fluctuations for USPH.Check CANO's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
USPH vs FPCG Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas FPCG's P/E ratio is 0.09. In terms of profitability, USPH's ROE is -0.01%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, USPH is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for USPH.Check FPCG's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
USPH vs FTRP Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas FTRP's P/E ratio is -1.22. In terms of profitability, USPH's ROE is -0.01%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, USPH is less volatile compared to FTRP. This indicates lower risk in terms of short-term price fluctuations for USPH.Check FTRP's competition here
American Shared Hospital Services (AMEX: AMS)
USPH vs AMS Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, AMS has a market cap of 8.4M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while AMS trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas AMS's P/E ratio is -5.03. In terms of profitability, USPH's ROE is -0.01%, compared to AMS's ROE of -0.07%. Regarding short-term risk, USPH is more volatile compared to AMS. This indicates higher risk in terms of short-term price fluctuations for USPH.Check AMS's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
USPH vs BMGL Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, BMGL has a market cap of 6.6M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while BMGL trades at $4.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas BMGL's P/E ratio is -0.84. In terms of profitability, USPH's ROE is -0.01%, compared to BMGL's ROE of -1.64%. Regarding short-term risk, USPH is less volatile compared to BMGL. This indicates lower risk in terms of short-term price fluctuations for USPH.Check BMGL's competition here
ModivCare Inc. (NASDAQ: MODV)
USPH vs MODV Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas MODV's P/E ratio is -0.06. In terms of profitability, USPH's ROE is -0.01%, compared to MODV's ROE of +0.88%. Regarding short-term risk, USPH is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for USPH.Check MODV's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
USPH vs GBNH Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas GBNH's P/E ratio is -0.06. In terms of profitability, USPH's ROE is -0.01%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, USPH is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for USPH.Check GBNH's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
USPH vs RHE-PA Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, USPH's ROE is -0.01%, compared to RHE-PA's ROE of +1.09%. Regarding short-term risk, USPH is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for USPH.Check RHE-PA's competition here
Regional Health Properties, Inc. (AMEX: RHE)
USPH vs RHE Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas RHE's P/E ratio is -1.79. In terms of profitability, USPH's ROE is -0.01%, compared to RHE's ROE of +1.09%. Regarding short-term risk, USPH is less volatile compared to RHE. This indicates lower risk in terms of short-term price fluctuations for USPH.Check RHE's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
USPH vs TOIIW Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, TOIIW has a market cap of 4.7M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas TOIIW's P/E ratio is -0.17. In terms of profitability, USPH's ROE is -0.01%, compared to TOIIW's ROE of +2.10%. Regarding short-term risk, USPH is more volatile compared to TOIIW. This indicates higher risk in terms of short-term price fluctuations for USPH.Check TOIIW's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
USPH vs AIDX Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, AIDX has a market cap of 3.4M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while AIDX trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas AIDX's P/E ratio is -0.37. In terms of profitability, USPH's ROE is -0.01%, compared to AIDX's ROE of -3.87%. Regarding short-term risk, USPH is more volatile compared to AIDX. This indicates higher risk in terms of short-term price fluctuations for USPH.Check AIDX's competition here
Starling Oncology Inc. Wt (NASDAQ: STLNW)
USPH vs STLNW Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, STLNW has a market cap of 2.8M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while STLNW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas STLNW's P/E ratio is -0.09. In terms of profitability, USPH's ROE is -0.01%, compared to STLNW's ROE of +2.10%. Regarding short-term risk, USPH is less volatile compared to STLNW. This indicates lower risk in terms of short-term price fluctuations for USPH.Check STLNW's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
USPH vs IMACW Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas IMACW's P/E ratio is N/A. In terms of profitability, USPH's ROE is -0.01%, compared to IMACW's ROE of +0.46%. Regarding short-term risk, USPH is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for USPH.Check IMACW's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
USPH vs EUDAW Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, EUDAW has a market cap of 971.7K. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while EUDAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas EUDAW's P/E ratio is -0.02. In terms of profitability, USPH's ROE is -0.01%, compared to EUDAW's ROE of -5.06%. Regarding short-term risk, USPH is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for USPH.Check EUDAW's competition here
Endovia Health Sciences, Inc. (AMEX: EDVA)
USPH vs EDVA Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, EDVA has a market cap of 947.8K. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while EDVA trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas EDVA's P/E ratio is -0.01. In terms of profitability, USPH's ROE is -0.01%, compared to EDVA's ROE of N/A. Regarding short-term risk, USPH is less volatile compared to EDVA. This indicates lower risk in terms of short-term price fluctuations for USPH.Check EDVA's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
USPH vs CCM Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, CCM has a market cap of 612.9K. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while CCM trades at $4.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas CCM's P/E ratio is -1.42. In terms of profitability, USPH's ROE is -0.01%, compared to CCM's ROE of +0.05%. Regarding short-term risk, USPH is less volatile compared to CCM. This indicates lower risk in terms of short-term price fluctuations for USPH.Check CCM's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
USPH vs NIVFW Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, NIVFW has a market cap of 35K. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas NIVFW's P/E ratio is N/A. In terms of profitability, USPH's ROE is -0.01%, compared to NIVFW's ROE of -292.08%. Regarding short-term risk, USPH is more volatile compared to NIVFW. This indicates higher risk in terms of short-term price fluctuations for USPH.Check NIVFW's competition here
Talkspace, Inc. (NASDAQ: TALKW)
USPH vs TALKW Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas TALKW's P/E ratio is 0.00. In terms of profitability, USPH's ROE is -0.01%, compared to TALKW's ROE of +0.00%. Regarding short-term risk, USPH is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for USPH.Check TALKW's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
USPH vs MNDR Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, MNDR has a market cap of 20.9K. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while MNDR trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas MNDR's P/E ratio is -0.06. In terms of profitability, USPH's ROE is -0.01%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, USPH is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for USPH.Check MNDR's competition here
Tenon Medical, Inc. (NASDAQ: TNONW)
USPH vs TNONW Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, TNONW has a market cap of 5.8K. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while TNONW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas TNONW's P/E ratio is N/A. In terms of profitability, USPH's ROE is -0.01%, compared to TNONW's ROE of N/A. Regarding short-term risk, USPH is less volatile compared to TNONW. This indicates lower risk in terms of short-term price fluctuations for USPH.Check TNONW's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
USPH vs NIVF Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, NIVF has a market cap of 3.9K. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while NIVF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas NIVF's P/E ratio is 0.12. In terms of profitability, USPH's ROE is -0.01%, compared to NIVF's ROE of -292.08%. Regarding short-term risk, USPH is less volatile compared to NIVF. This indicates lower risk in terms of short-term price fluctuations for USPH.Check NIVF's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
USPH vs ATIP-WT Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, USPH's ROE is -0.01%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, USPH is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for USPH.Check ATIP-WT's competition here
Hanger, Inc. (NYSE: HNGR)
USPH vs HNGR Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, HNGR has a market cap of 0. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas HNGR's P/E ratio is 19.71. In terms of profitability, USPH's ROE is -0.01%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, USPH is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for USPH.Check HNGR's competition here
DocGo Inc. (NASDAQ: DCGOW)
USPH vs DCGOW Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas DCGOW's P/E ratio is N/A. In terms of profitability, USPH's ROE is -0.01%, compared to DCGOW's ROE of -1.16%. Regarding short-term risk, USPH is less volatile compared to DCGOW. This indicates lower risk in terms of short-term price fluctuations for USPH.Check DCGOW's competition here
Almost Family Inc. (NASDAQ: AFAM)
USPH vs AFAM Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, AFAM has a market cap of 0. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas AFAM's P/E ratio is N/A. In terms of profitability, USPH's ROE is -0.01%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, USPH is less volatile compared to AFAM. This indicates lower risk in terms of short-term price fluctuations for USPH.Check AFAM's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
USPH vs TLMD Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, TLMD has a market cap of 0. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas TLMD's P/E ratio is -1.60. In terms of profitability, USPH's ROE is -0.01%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, USPH is more volatile compared to TLMD. This indicates higher risk in terms of short-term price fluctuations for USPH.Check TLMD's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
USPH vs TVTY Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, TVTY has a market cap of 0. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas TVTY's P/E ratio is 19.06. In terms of profitability, USPH's ROE is -0.01%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, USPH is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for USPH.Check TVTY's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
USPH vs SLHGP Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, USPH's ROE is -0.01%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, USPH is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for USPH.Check SLHGP's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
USPH vs SLHG Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, SLHG has a market cap of 0. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas SLHG's P/E ratio is -1.48. In terms of profitability, USPH's ROE is -0.01%, compared to SLHG's ROE of N/A. Regarding short-term risk, USPH is less volatile compared to SLHG. This indicates lower risk in terms of short-term price fluctuations for USPH.Check SLHG's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
USPH vs TLMDW Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas TLMDW's P/E ratio is N/A. In terms of profitability, USPH's ROE is -0.01%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, USPH is less volatile compared to TLMDW. This indicates lower risk in terms of short-term price fluctuations for USPH.Check TLMDW's competition here
New Frontier Health Corporation (NYSE: NFH)
USPH vs NFH Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, NFH has a market cap of 0. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas NFH's P/E ratio is -19.75. In terms of profitability, USPH's ROE is -0.01%, compared to NFH's ROE of -0.06%. Regarding short-term risk, USPH is more volatile compared to NFH. This indicates higher risk in terms of short-term price fluctuations for USPH.Check NFH's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
USPH vs DVCR Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, DVCR has a market cap of 0. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas DVCR's P/E ratio is 28.34. In terms of profitability, USPH's ROE is -0.01%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, USPH is more volatile compared to DVCR. This indicates higher risk in terms of short-term price fluctuations for USPH.Check DVCR's competition here
Kindred Healthcare, Inc. (NYSE: KND)
USPH vs KND Comparison October 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USPH stands at 1.3B. In comparison, KND has a market cap of 0. Regarding current trading prices, USPH is priced at $87.02 on the NYSE, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USPH currently has a P/E ratio of 34.24, whereas KND's P/E ratio is -1.14. In terms of profitability, USPH's ROE is -0.01%, compared to KND's ROE of -0.53%. Regarding short-term risk, USPH is more volatile compared to KND. This indicates higher risk in terms of short-term price fluctuations for USPH.Check KND's competition here